Hepatitis Monthly

Published by: Kowsar

The Activation of Cytomegalovirus and Human Herpes Virus 6 After Liver Transplantation

Amir Nasimfar 1 , Ebrahim Sadeghi 1 , * , Abdolvahab Alborzi 2 , Nariman Sepehrvand 1 , Mazyar Ziyaeyan 2 , Marzieh Jamalidoust 2 and Sayed Ali Malek-Hosseini 3
Authors Information
1 Department of Pediatrics, Urmia University of Medical Sciences, Urmia, IR Iran
2 Prof. Alborzi Clinical Microbiology Research Center, Shiraz University of Medical Sciences, Nemazee Hospital, Shiraz, Iran
3 Organ Transplantation Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
Article information
  • Hepatitis Monthly: February 2018, 18 (2); e11987
  • Published Online: January 31, 2018
  • Article Type: Research Article
  • Received: April 23, 2017
  • Revised: December 3, 2017
  • Accepted: January 8, 2018
  • DOI: 10.5812/hepatmon.11987

To Cite: Nasimfar A, Sadeghi E, Alborzi A, Sepehrvand N, Ziyaeyan M, et al. The Activation of Cytomegalovirus and Human Herpes Virus 6 After Liver Transplantation, Hepat Mon. 2018 ; 18(2):e11987. doi: 10.5812/hepatmon.11987.

Copyright © 2018, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
  • 1. Saidi RF. Current status of liver transplantation. Arch Iran Med. 2012;15(12):772-6. [PubMed: 23199251].
  • 2. Aguirre-Valadez J, Torre A, Vilatoba M, Contreras A, Sanchez-Cedillo A, Antolinez-Motta J, et al. [Indications for liver transplant]. Rev Invest Clin. 2014;66(6):534-46. [PubMed: 25729871].
  • 3. De Bolle L, Naesens L, De Clercq E. Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev. 2005;18(1):217-45. doi: 10.1128/CMR.18.1.217-245.2005. [PubMed: 15653828].
  • 4. Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z. Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells. Blood. 2002;99(8):2913-21. [PubMed: 11929782].
  • 5. Raftery MJ, Schwab M, Eibert SM, Samstag Y, Walczak H, Schonrich G. Targeting the function of mature dendritic cells by human cytomegalovirus: a multilayered viral defense strategy. Immunity. 2001;15(6):997-1009. [PubMed: 11754820].
  • 6. Tomazin R, Boname J, Hegde NR, Lewinsohn DM, Altschuler Y, Jones TR, et al. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. Nat Med. 1999;5(9):1039-43. doi: 10.1038/12478. [PubMed: 10470081].
  • 7. Bowden RA, Ljungman P, Snydman DR. Transplant infections. Lippincott Williams & Wilkins; 2012.
  • 8. Sepehrvand N, Khameneh ZR, Eslamloo HRF. Survey the seroprevalence of CMV among hemodialysis patients in Urmia, Iran. Saudi J Kidney Dis Transplant. 2010;21(2):363.
  • 9. Rostamzadeh Khameneh Z, Rostamzadeh A, Nemati M, M. Brown P, Sepehrvand N. Cytomegalovirus Infection and Coronary Artery Disease: A Single-Center Serological Study in Northwestern Iran. Int Cardivasc Res J. 2016;Inpress(Inpress). doi: 10.17795/icrj-10(03)118.
  • 10. Burbelo PD, Bayat A, Wagner J, Nutman TB, Baraniuk JN, Iadarola MJ. No serological evidence for a role of HHV-6 infection in chronic fatigue syndrome. Am J Transl Res. 2012;4(4):443-51. [PubMed: 23145212].
  • 11. Politou M, Koutras D, Kaparos G, Valsami S, Pittaras T, Logothetis E, et al. Seroprevalence of HHV-6 and HHV-8 among blood donors in Greece. Virol J. 2014;11:153. doi: 10.1186/1743-422X-11-153. [PubMed: 25163521].
  • 12. Razonable RR, Paya CV. Infections and allograft rejection - intertwined complications of organ transplantation. Swiss Med Wkly. 2005;135(39-40):571-3. [PubMed: 16333768].
  • 13. Razonable RR, Emery VC. Management of CMV infection and disease in transplant patients. 27-29 February 2004. Herpes J IHMF. 2004;11(3):77-86.
  • 14. Razonable RR, Paya CV. Herpesvirus infections in transplant recipients: current challenges in the clinical management of cytomegalovirus and Epstein-Barr virus infections. Herpes. 2003;10(3):60-5. [PubMed: 14759337].
  • 15. Khameneh ZR, Sepehrvand N, Aghazadeh T. Cytomegalovirus infection among Iranian kidney graft recipients. Transplant Proc. 2013;45(1):178-81. doi: 10.1016/j.transproceed.2012.09.115. [PubMed: 23375294].
  • 16. Dockrell DH, Prada J, Jones MF, Patel R, Badley AD, Harmsen WS, et al. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis. 1997;176(5):1135-40. [PubMed: 9359710].
  • 17. Mendez J, Espy M, Smith TF, Wilson J, Wiesner R, Paya CV. Clinical significance of viral load in the diagnosis of cytomegalovirus disease after liver transplantation. Transplantation. 1998;65(11):1477-81. [PubMed: 9645806].
  • 18. Razonable RR, Rivero A, Brown RA, Hart GD, Espy MJ, van Cruijsen H, et al. Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clin Transplant. 2003;17(2):114-20. [PubMed: 12709076].
  • 19. Lautenschlager I, Höckerstedt K, Linnavuori K, Taskinen E. Human Herpesvirus‐6 Infection After Liver Transplantation. Clin Infect Dis. 1998;26(3):702-7. doi: 10.1086/514592.
  • 20. Lautenschlager I, Linnavuori K, Lappalainen M, Suni J, Hockerstedt K. HHV-6 reactivation is often associated with CMV infection in liver transplant patients. Transpl Int. 2000;13 Suppl 1:S351-3. [PubMed: 11112030].
  • 21. Demetris A, Adams D, Bellamy C, Blakolmer K, Clouston A, Dhillon AP, et al. Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel. Hepatology. 2000;31(3):792-9. doi: 10.1002/hep.510310337. [PubMed: 10706577].
  • 22. Behzad-Behbahani A, Entezam M, Mojiri A, Pouransari R, Rahsaz M, Banihashemi M, et al. Incidence of human herpes virus-6 and human cytomegalovirus infections in donated bone marrow and umbilical cord blood hematopoietic stem cells. Indian J Med Microbiol. 2008;26(3):252-5. [PubMed: 18695326].
  • 23. Saadi MI, Yaghobi R, Karimi MH, Geramizadeh B, Ramzi M, Zakerinia M. Association of the costimulatory molecule gene polymorphisms and active cytomegalovirus infection in hematopoietic stem cell transplant patients. Mol Biol Rep. 2013;40(10):5833-42. doi: 10.1007/s11033-013-2689-x. [PubMed: 24057239].
  • 24. Niknam A, Karimi MH, Yaghobi R, Geramizadeh B, Roozbeh J, Salehipour M, et al. The Association Between Viral Infections and Co-stimulatory Gene Polymorphisms in Kidney Transplant Outcomes. Jundishapur J Microbiol. 2016;9(8). e31338. doi: 10.5812/jjm.31338. [PubMed: 27800130].
  • 25. Harma M, Hockerstedt K, Lyytikainen O, Lautenschlager I. HHV-6 and HHV-7 antigenemia related to CMV infection after liver transplantation. J Med Virol. 2006;78(6):800-5. doi: 10.1002/jmv.20626. [PubMed: 16628583].
  • 26. Humar A, Malkan G, Moussa G, Greig P, Levy G, Mazzulli T. Human herpesvirus-6 is associated with cytomegalovirus reactivation in liver transplant recipients. J Infect Dis. 2000;181(4):1450-3. doi: 10.1086/315391. [PubMed: 10762575].
  • 27. Saghafi H, Qorashi M, Heidari A. Is screening for IgG antibody to cytomegalovirus and Epstein-Barr virus infections mandatory in potential renal transplant recipients and donors in Iran?. Transplant Proc. 2009;41(7):2761-3. doi: 10.1016/j.transproceed.2009.07.057. [PubMed: 19765428].
  • 28. Eid AJ, Razonable RR. Cytomegalovirus disease in solid organ transplant recipients: advances lead to new challenges and opportunities. Curr Opin Organ Transplant. 2007;12(6):610-7. doi: 10.1097/MOT.0b013e3282f0d386.
  • 29. Gane E, Saliba F, Valdecasas GJ, O'Grady J, Pescovitz MD, Lyman S, et al. Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]. Lancet. 1997;350(9093):1729-33. [PubMed: 9413463].
  • 30. Razonable RR. Cytomegalovirus infection after liver transplantation: current concepts and challenges. World J Gastroenterol. 2008;14(31):4849-60. [PubMed: 18756591].
  • 31. DesJardin JA, Cho E, Supran S, Gibbons L, Werner BG, Snydman DR. Association of human herpesvirus 6 reactivation with severe cytomegalovirus-associated disease in orthotopic liver transplant recipients. Clin Infect Dis. 2001;33(8):1358-62. doi: 10.1086/323336. [PubMed: 11565077].
  • 32. Harma M, Loginov R, Piiparinen H, Halme L, Hockerstedt K, Lautenschlager I. HHV-6-DNAemia related to CMV-DNAemia after liver transplantation. Transplant Proc. 2005;37(2):1230-2. doi: 10.1016/j.transproceed.2004.12.004. [PubMed: 15848678].
  • 33. Schulenburg A, Watkins-Riedel T, Greinix HT, Rabitsch W, Loidolt H, Keil F, et al. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR. Bone Marrow Transplant. 2001;28(8):765-8. doi: 10.1038/sj.bmt.1703227. [PubMed: 11781628].
  • 34. Abdel Massih RC, Razonable RR. Human herpesvirus 6 infections after liver transplantation. World J Gastroenterol. 2009;15(21):2561-9. [PubMed: 19496184].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments
  • SM Miri says:
    2018-04-25 07:20:24
    Dear EIC, It was better to mention type of study in the methods of abstract. Yours